Bionik Laboratories Corp.
Bionik Laboratories Corp. (BNKL) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
bnkl · pe ratio · data through Mar 31, 2023
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Bionik Laboratories Corp. (BNKL) measures how much investors pay for each dollar of the company's trailing earnings. BNKL's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.72.
Source: FMP · /ratios-ttm · /analyst-estimates · 2023-03-31
PE Ratio History
2010 – 2023 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Medical - Care Facilities · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Bionik Laboratories Corp.You BNKL | $0M | N/A | — | -$0.72 |
 Adynxx, Inc. ADYX | $0M | N/A | — | -$10.26 |
 BG Medicine, Inc. BGMD | $0M | N/A | — | -$0.55 |
 BIMI International Medical Inc. BIMI | $0M | N/A | — | -$8.40 |
 ContraFect Corporation CFRXQ | $0M | N/A | — | -$124.97 |
 FusionPharm, Inc. FSPM | $0M | N/A | — | — |
 Millennium Sustainable Ventures Corp. MILC | $0M | N/A | — | -$0.66 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2023-03-31Latest FY2023 | — | $-0.72 | — | |
2022-03-31 FY2022 | — | $-1.78 | — | |
2021-03-31 FY2021 | — | $-2.66 | — | |
2020-03-31 FY2020 | — | $-5.60 | — | |
2019-03-31 FY2019 | — | $-4.47 | — | |
2018-03-31 FY2018 | — | $-21.88 | — | |
2017-03-31 FY2017 | — | $-6.43 | — | |
2016-03-31 FY2016 | 69.06x | $2.17 | — | |
2014-12-31 FY2014 | — | $-0.06 | — | |
2013-12-31 FY2013 | — | $-0.02 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Bionik Laboratories Corp. (BNKL) measures how much investors pay for each dollar of the company's trailing earnings. BNKL's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.72.
Frequently asked questions
BNKL pe ratio · 6 questionsBNKL's current PE ratio is N/A as of 2026-06-08, based on a stock price of $0.00 and TTM EPS of -$0.72. Data sourced from Financial Modeling Prep via BNKL's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Bionik Laboratories Corp. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08